Tengion Inc.
2900 Potshop Lane East
Suite 100
Norriton
Pennsylvania
19403
United States
Tel: 610-292-8364
Website: http://www.tengion.com/
121 articles about Tengion Inc.
-
Cabaletta Bio launched out of the University of Pennsylvania with an exclusive license deal and two multi-year sponsored research agreements. The fledgling biotech company will work on engineered T cell products for B cell-mediated autoimmune disease.
-
Tengion Inc. Provides Clinical Update And Reports Third Quarter 2014 Financial Results And Cash Position
11/17/2014
-
Tengion Inc. Brings In Jefferies and Co. To Explore Strategic Options
9/22/2014
-
Tengion Inc. Provides Clinical Update And Reports Second Quarter 2014 Financial Results
8/13/2014
-
Tengion Inc. Reports Fourth Quarter And Full Year 2013 Financial Results
3/27/2014
-
Tengion Inc. To Present At The 26th Annual ROTH Conference
3/5/2014
-
Tengion Inc. Announces Continued Clinical Progress In Its Two Lead Programs
1/13/2014
-
Tengion Inc. Provides Business Update and Reports Second Quarter 2013 Financial Results
8/15/2013
-
Tengion Inc. Raises $74 Million for Organ Programs
8/8/2013
-
Tengion Inc. Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance
8/7/2013
-
Tengion Inc. Raises $33.6 Million to Stay Alive
7/2/2013
-
Tengion Inc. to Participate in Panel Discussion at International Society for Stem Cell Research 11th Annual Meeting
6/13/2013
-
Tengion Inc. Provides Business Update and Reports First Quarter 2013 Financial Results
5/15/2013
-
Tengion Inc. Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
4/1/2013
-
Tengion Inc. Provides Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results
3/18/2013
-
Tengion Inc. to Present at 25th Annual ROTH Conference
3/12/2013
-
Tengion Inc. to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013
3/12/2013
-
Tengion Inc. to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/5/2013
-
Tengion Inc. Announces Clinical Progress for Neo-Urinary Conduit™ Phase 1 Trial and Regulatory Advance for Neo-Kidney Augment™
1/31/2013
-
Tengion Inc. Announces Change to Board of Directors
12/21/2012